LOS ANGELES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)HIRSHBERG FOUNDATION FOR PANCREATIC CANC, founded in 1997, is a community nonprofit in the Philanthropy & Grantmaking sector that reported $2.8M in total revenue in fiscal year 2024. Expenses of $3.1M exceeded revenue, resulting in a 11% operating deficit.
FOUNDED IN 1997, THE HIRSHBERG FOUNDATION FOR PANCREATIC CANCER RESEARCH IS A NATIONAL, NONPROFIT ORGANIZATION DEDICATED TO ADVANCING PANCREATIC CANCER RESEARCH, AND PROVIDING INFORMATION, RESOURCES, AND SUPPORT TO PANCREATIC CANCER PATIENTS AND THEIR FAMILIES.
THE RESEARCH PROGRAMS INCLUDE VARIOUS GRANTS AND COMMITMENTS TO FURTHER RESEARCH INTO FINDING A CURE FOR PANCREATIC CANCER. THROUGH OUR SEED GRANT PROGRAM WE SUPPORT BASIC AND CLINICAL SCIENTISTS AND...
THE RESEARCH PROGRAMS INCLUDE VARIOUS GRANTS AND COMMITMENTS TO FURTHER RESEARCH INTO FINDING A CURE FOR PANCREATIC CANCER. THROUGH OUR SEED GRANT PROGRAM WE SUPPORT BASIC AND CLINICAL SCIENTISTS AND INVESTIGATORS IN THE U.S. AND ABROAD, AWARDING MORE THAN 130 GRANTS SINCE 2005 AND FUNDING MORE THAN 50 MEDICAL RESEARCH INSTITUTIONS GLOBALLY. THE UCLA AGI HIRSHBERG CENTER FOR PANCREATIC DISEASES PROVIDES A CRITICAL HUB FOR ADVANCING RESEARCH AND TREATMENT BREAKTHROUGHS. WE FUND 3 LABORATORIES AT UCLA FOCUSING ON BASIC AND TRANSLATIONAL SCIENCE. WE FUND A PANCREAS TISSUE BANK.
THE PATIENT SUPPORT PROGRAMS PROVIDE INFORMATION AND GUIDANCE TO PATIENTS AND CAREGIVERS, INCLUDING COUNSELING AND SUPPORT GROUPS, ALTERNATIVE MEDICINE, CLINICAL TRIAL UPDATES, PATIENT ADVOCACY...
THE PATIENT SUPPORT PROGRAMS PROVIDE INFORMATION AND GUIDANCE TO PATIENTS AND CAREGIVERS, INCLUDING COUNSELING AND SUPPORT GROUPS, ALTERNATIVE MEDICINE, CLINICAL TRIAL UPDATES, PATIENT ADVOCACY, FINANCIAL AID AND GENETIC COUNSELING. OUR ANNUAL SYMPOSIUM IS A PATIENT CENTERED EDUCATION PROGRAM THAT HAS INTEGRATED NEARLY 200 RESEARCHERS, CLINICIANS, PATIENTS AND FAMILIES TO LEARN ABOUT DEVELOPMENTS, TREATMENTS AND PROGRESSION OF FINDING A CURE. OUR PATIENT AND FAMILY WEBINAR SERIES IS AN INTERACTIVE SERIES CONNECTING SPECIALISTS WITH THE PANCREATIC CANCER COMMUNITY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $2,786,197 | $2,843,867 | 0.0% |
| Expenses | $3,081,348 | $3,053,051 | +0.0% |
| Net Income | $-295,151 | $-209,184 | +0.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| LISA MANHEIM | CHIEF EXECUTIVE OFFICER, DIRECTOR | 40.00 |
Officer
Director
|
$275,003 | $0 | $275,003 |
| AGNES BERLINER HIRSHBERG | DIRECTOR, PRESIDENT | 40.00 |
Officer
Director
|
$0 | $6,356 | $6,356 |
| MICHAEL SCOTT ESQ | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JON HIRSHBERG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LISA HIRSHBERG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL BERLINER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LEONARD ALTADONNA CPA | ACTING TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $2,786,197 | $3,081,348 | $3,383,563 | $-295,151 |
| 2023 | $2,843,867 | $3,053,051 | $3,579,571 | $-209,184 |
| 2022 | $2,416,101 | $2,647,573 | $3,413,242 | $-231,472 |
| 2021 | $2,209,480 | $1,530,515 | $3,850,011 | $678,965 |
| 2020 | $1,637,179 | $1,208,727 | $3,171,046 | $428,452 |
| 2019 | $1,997,583 | $1,206,613 | $2,742,594 | $790,970 |
| 2018 | $1,815,639 | $1,398,999 | $1,951,354 | $416,640 |
| 2017 | $1,835,142 | $1,670,150 | $1,534,713 | $164,992 |
Compare HIRSHBERG FOUNDATION FOR PANCREATIC CANC with other nonprofits in California and across the country.